Protocol for an HIV Pre-exposure Prophylaxis (PrEP) Population Level Intervention Study in Victoria Australia: The PrEPX Study

Background: Pre-exposure prophylaxis (PrEP) is the use of HIV anti-retroviral therapy to prevent HIV transmission in people at high risk of HIV acquisition. PrEP is highly efficacious when taken either daily, or in an on-demand schedule. In Australia co-formulated tenofovir-emtricitabine is register...

Full description

Bibliographic Details
Main Authors: Kathleen E. Ryan, Anne Mak, Mark Stoove, Brian Price, Christopher K. Fairley, Simon Ruth, Luxshimi Lal, Jason Asselin, Carol El-Hayek, Long Nguyen, Colin Batrouney, David Wilson, John Lockwood, Dean Murphy, Vincent J. Cornelisse, Norman Roth, Jeff Willcox, Christina C. Chang, Judy Armishaw, Ban K. Tee, Matthew Penn, George Forgan-Smith, Christopher Williams, Jeff Montgomery, Kat Byron, Alison Coelho, Brent Allen, Jeremy Wiggins, Jenny Kelsall, Olga Vujovic, Michael West, Anna B. Pierce, Daniel Gallant, Charlotte Bell, John B. F. de Wit, Jennifer F. Hoy, Steve L. Wesselingh, Robert M. Grant, Edwina J. Wright
Format: Article
Published: Frontiers Media S.A. 2018-05-01
Series:Frontiers in Public Health
Online Access: